241 studies found for:    "Hemophilia A"
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor
Conditions: Hemophilia A;   Hemophilia B;   (High-titer) Factor VIII Inhibitor;   (High-titer) Factor IX Inhibitor
Intervention: Biological: Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
2 Not yet recruiting An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Conditions: Hemophilia A;   Severe Hemophilia A
Intervention: Biological: rVIII‑SingleChain
3 Completed A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia A With Inhibitors;   Haemophilia B;   Haemophilia B With Inhibitors
Intervention: Drug: eptacog alfa (activated)
4 Suspended Study of Ataluren (PTC124®) in Hemophilia A and B
Conditions: Hemophilia A;   Hemophilia B
Intervention: Drug: Ataluren (PTC124)
5 Completed Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A
Condition: Hemophilia A
Intervention: Biological: OBI-1
6 Terminated Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A
Condition: Hemophilia A
Intervention: Biological: OBI-1
7 Completed Clot Formation and Clot Stability in Patients With Severe Haemophilia A
Condition: Hemophilia A
Intervention: Drug: ReFacto (Recombinant factor VIII) and Tranexamic acid
8 Terminated Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
Condition: Hemophilia A
Interventions: Drug: Rituxan;   Drug: prednisone
9 Completed Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
Condition: Hemophilia A
Intervention: Drug: GreenGene
10 Recruiting Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients
Condition: Haemophilia A
Intervention: Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
11 Active, not recruiting Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A
Condition: Hemophilia A
Intervention: Biological: BAY94-9027
12 Recruiting Inhibitor Development in Patients With Hemophilia A Undergoing Surgery
Condition: Hemophilia A
Intervention:
13 Completed
Has Results
Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A
Conditions: Blood Coagulation Disorders;   Hemophilia A
Interventions: Biological: Recombinant Factor VIII (BAY81-8973);   Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
14 Active, not recruiting Platelet Function in Patients With Hemophilia A
Condition: Hemophilia A
Intervention:
15 Completed Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay
Condition: Hemophilia A
Intervention: Device: FVIII immuno-assay
16 Completed Study Evaluating Approach to Treatment of Haemophilia A and B in Spain
Conditions: Hemophilia A;   Hemophilia B
Intervention:
17 Completed Study of Biostate® in Children With Hemophilia A
Condition: Hemophilia A
Intervention: Biological: Biostate
18 Completed Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia A
Condition: Hemophilia A
Interventions: Biological: Biostate® [SP];   Biological: Biostate® [RP]
19 Recruiting Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
Condition: Severe Hemophilia A
Intervention: Drug: Alphanate SD/HT
20 Terminated Individually Tailored Prophylaxis in Patients With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Drug: FVIII

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years